Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (62)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dumble, M. L.
Right arrow Articles by Quail, E. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumble, M. L.
Right arrow Articles by Quail, E. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 3, 435-445, March 2002
© 2002 Oxford University Press


CARCINOGENESIS

Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma

Melissa L. Dumble, Emma J. Croager, George C.T. Yeoh and Elizabeth A Quail,1

Department of Biochemistry, The University of Western Australia, Crawley, 6009, Australia

Oval cells are bipotential liver stem cells able to differentiate into hepatocytes and bile duct epithelia. In normal adult liver oval cells are quiescent, existing in low numbers around the periportal region, and proliferate following severe, prolonged liver trauma. There is evidence implicating oval cells in the development of hepatocellular carcinoma, and hence the availability of an immortalized oval cell line would be invaluable for the study of liver cell lineage differentiation and carcinogenesis. A novel approach in the generation of cell lines is the use of the p53 knockout mouse. Absence of p53 allows a cell to cycle past the normal Hayflick limit, rendering it immortalized, although subsequent genetic alterations are thought necessary for transformation. p53 knockout mice were fed a choline-deficient, ethionine-supplemented diet, previously shown to increase oval cell numbers in wild-type mice. The oval cells were isolated by centrifugal elutriation and maintained in culture. Colonies of hepatic cells were isolated and characterized with respect to phenotype, growth characteristics and tumorigenicity. Analysis of gene expression by Northern blotting and immunocytochemistry suggests they are oval-like cells by virtue of albumin and transferrin expression, as well as the oval cell markers alpha fetoprotein, M2-pyruvate kinase and A6. Injection into athymic nude mice shows the cell lines are capable of forming tumors which phenotypically resemble hepatocellular carcinoma. Thus, the use of p53 null hepatic cells successfully generated immortalized and tumorigenic hepatic stem cell lines. The results presented support the idea that deleting p53 allows immortalization and contributes to the transformation of the oval-like cell lines. Further, the tumorigenic status of the cell lines is direct evidence for the participation of oval cells in the formation of hepatocellular carcinoma.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. M. Jellicoe, S. J. Nichols, B. A. Callus, M. V. Baker, P. J. Barnard, S. J. Berners-Price, J. Whelan, G. C. Yeoh, and A. Filipovska
Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound
Carcinogenesis, June 1, 2008; 29(6): 1124 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. B. Rountree, L. Barsky, S. Ge, J. Zhu, S. Senadheera, and G. M. Crooks
A CD133-Expressing Murine Liver Oval Cell Population with Bilineage Potential
Stem Cells, October 1, 2007; 25(10): 2419 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. Tsuchiya, T. Heike, S. Baba, H. Fujino, K. Umeda, Y. Matsuda, M. Nomoto, T. Ichida, Y. Aoyagi, and T. Nakahata
Long-Term Culture of Postnatal Mouse Hepatic Stem/Progenitor Cells and Their Relative Developmental Hierarchy
Stem Cells, April 1, 2007; 25(4): 895 - 902.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. A. Davies, B. Knight, Y. W. Tian, G. C.T. Yeoh, and J. K. Olynyk
Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor
Carcinogenesis, August 1, 2006; 27(8): 1607 - 1616.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Knight, B. B. Yeap, G. C. Yeoh, and J. K. Olynyk
Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member {gamma}, but not {alpha} or {delta}
Carcinogenesis, October 1, 2005; 26(10): 1782 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Vondracek, M. Machala, V. Bryja, K. Chramostova, P. Krcmar, C. Dietrich, A. Hampl, and A. Kozubik
Aryl Hydrocarbon Receptor-Activating Polychlorinated Biphenyls and Their Hydroxylated Metabolites Induce Cell Proliferation in Contact-Inhibited Rat Liver Epithelial Cells
Toxicol. Sci., January 1, 2005; 83(1): 53 - 63.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Tan, P. G. Besant, X. L. Zu, C. W. Turck, M. A. Bogoyevitch, S. G. Lim, P. V. Attwood, and G. C. Yeoh
Histone H4 histidine kinase displays the expression pattern of a liver oncodevelopmental marker
Carcinogenesis, November 1, 2004; 25(11): 2083 - 2088.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Ishikawa, K Nakao, K Matsumoto, D Nishimura, T Ichikawa, K Hamasaki, and K Eguchi
Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma
Gut, June 1, 2004; 53(6): 884 - 889.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.